Piramal Pharma Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide.
One of their notable products is TRAMADOL HYDROCHLORIDE, with a corresponding US DMF Number 24954.
Remarkably, this DMF maintains an Active status since its submission on May 06, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 04, 2013, and payment made on August 23, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II